General Updates

Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. SUN Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 PHARMA Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 06 August 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Intimation under Regulation 30 and Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Receipt of No-objection letters from the Stock Exchanges Further to our earlier intimations dated 14 May 2026, 22 May 2026, and 26 May 2026, this is to inform that the Company has received No-Objection Letters dated 06 August 2026 from the National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”) for reclassification of the persons referred to in our intimation dated 14 May 2026 from the ‘Promoter Group’ category to the ‘Public’ category in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Copies of No-objection letters from NSE and BSE are attached as Annexure A and Annexure B respectively, and the same are also available on the Company’s website at www.sunpharma.com. This intimation is being made in compliance with the provisions of the SEBI Listing Regulations. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA. Reaching People. Touching Lives. Annexure A NiftySO Ref: NSE/LIST/COMP/SUNPHARMA/600/2026-2027 Date: August 06, 2026 The Company Secretary Sun Pharmaceutical Industries Limited (‘the Listed Entity') SPARC, Tandalja, Vadodara - 390012, Gujarat Vadodara 390012 Subject: No-objection letter for Reclassification of Promoter(s) / Promoter Group(s) under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir / Madam, This is in reference to your application dated May 26, 2026, requesting a no-objection letter for the Reclassification of promoter group under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Based on the submission made by the Listed Entity, the Exchange grants No-objection letter for the Reclassification application dated May 26, 2026, for the following promoter group in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sr. No. Promoter Group 1. Krishna Vrundavandas Valia 2. Sudhir Vrundavandas Valia 3. Raksha Sudhir Valia You are required to ensure compliance with subsequent relevant disclosures of material events related to this reclassification, in accordance with the applicable provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Yours faithfully, for National Stock Exchange of India Limited Ajit Mahadik Senior Manager – Listing Compliance CC: National Securities Depository Limited Central Depository Services Limited 301, G-Block, Plot No. C-32, Naman Chambers, Marathon Futurex, A-Wing, [ II 3rd Floor, Bandra Kurla Complex, Bandra East, 25th floor, NM Joshi Marg, Mumbai, Maharashtra, 400051 Lower Parel, Mumbai - 400 073 II This Document is Digitally Signed Signed by: Ajit Dattaram Mahadik Date: Thu, Aug 6, 2026 16:06:42 IST NSE Location: NSE Nat1orral Stod< Exchante of llldia L1m1ted I Excha11fle Plaza. C-1. Block G, Balldra Ku 1dra (E). Mumbal - 400 0 Sl, llldia+9122 265911100 I www.11se1lldia.com I CIN U67120MH1992PLC069769 Annexure B The Power of Vibrance LIST /COMP /KR/163/2026-27 August 06, 2026 The Company Secretary/ Compliance Officer Sun Pharmaceutical Industries Ltd SPARC, Tandalja, Vadodara, Gujarat, 390012 Subject: No-objection for reclassification of Promoter(s) under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, This is in reference to your application dated May 26, 2026, requesting no-objection for the reclassification of promoter(s) under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Based on the submission made by the Listed Entity, the Exchange grants no-objection for the reclassification request dated May 26, 2026, for the following promoter(s) in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sr.No. Name of Promoter(s) / Promoter(s) Group 1. Sudhir Vrundavandas Valia 2. Krishna Vrundavandas Valia 3. Raksha Sudhir Valia You are required to ensure compliance with subsequent relevant disclosures of material events related to this reclassification, in accordance with the applicable provisions of Regulation 31A of SEBI (LODR) Regulations, 2015. Yours faithfully, \,, ~. 9-.0..W Jayshree Soni Deputy Vice President Deputy Manager Listing Compliance Listing Compliance cc National Securities Depository Limited Central Depository Services Limited 301, G-Slock, Plot No. C-32, Naman Chambers, Marathon Futurex, A- Wing, 25th Floor, 3rd Floor, Sandra Kurla Complex, NM Joshi Marg, Lower Parel, Mumbai - 400 073 Sandra East, Mumbai -400051 Reclassification of Promoters: Sun Pharmaceutical Industries Ltd Registered Office: BSE Limited, Floor 25, P J Towers, Dalal Street, Mumbai -400 001, India. T: +91 22 2272 1234/33 I E: corp.comm@bseindia.com www.bseindia.com I Corporate Identity Number: L67120MH2005PLC155188